| P50 | author | Heidi M Soeters | Q47696585 |
| | Anne F Rositch | Q55203862 |
| P2093 | author name string | Jennifer S Smith | |
| | Tabatha N Offutt-Powell | |
| | Sylvia M Taylor | |
| | Bradford S Wheeler | |
| P2860 | cites work | 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ | Q28251233 |
| | Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser | Q30965313 |
| | Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil | Q30984012 |
| | PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia | Q33318598 |
| | Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study | Q33444450 |
| | Role of HPV testing in the follow-up of women treated for cervical dysplasia | Q33518644 |
| | Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa | Q33619797 |
| | High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis | Q34135249 |
| | Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data | Q34210255 |
| | Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group | Q34313864 |
| | A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica | Q34557325 |
| | Persistence of human papillomavirus DNA in cervical lesions after treatment with diathermic large loop excision. | Q35615531 |
| | Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment | Q35907158 |
| | Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia | Q36311966 |
| | Persistent HPV infection after conization in patients with negative margins | Q36357318 |
| | Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study | Q36365585 |
| | Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women | Q36442227 |
| | Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia | Q36622802 |
| | Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections | Q36671765 |
| | Efficacy of CO2 laser surgery in treating squamous intraepithelial lesions. An analysis of clinical and virologic results. | Q36724087 |
| | Factors associated with HPV persistence after conization in patients with negative margins | Q37248557 |
| | Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections | Q37467424 |
| | 1 Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus | Q40438662 |
| | Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping | Q44404067 |
| | High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes. | Q44475628 |
| | Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? | Q44707482 |
| | Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens | Q44830999 |
| | Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - A prospective study. | Q44882841 |
| | 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. | Q46027527 |
| | Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment | Q46517601 |
| | Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia | Q49162052 |
| | Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. | Q51036686 |
| | Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure. | Q51558528 |
| | Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. | Q53411351 |
| | Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins. | Q54379431 |
| | Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. | Q54402491 |
| | Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. | Q54588209 |
| | Persistence of Human Papillomavirus Infection after Therapeutic Conization for CIN 3: Is It an Alarm for Disease Recurrence? | Q56638144 |
| | Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer | Q57089472 |
| | Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection | Q57655463 |
| | Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation | Q57703255 |
| | The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia | Q63914905 |
| | Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri | Q73538537 |
| | Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology | Q74447110 |
| | Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia | Q78494093 |
| | Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ) | Q80884020 |
| | Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease | Q82798966 |
| | Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study | Q83365397 |
| | Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions | Q84957025 |
| | Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010 | Q85083866 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human papillomavirus infection | Q184627 |
| P304 | page(s) | 767-779 | |
| P577 | publication date | 2014-01-07 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review | |
| P478 | volume | 132 | |